BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19188502)

  • 1. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
    Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
    Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
    Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
    Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
    Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
    Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
    Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
    J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
    Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model.
    Shim WS; Li W; Zhang L; Li S; Ong HC; Song IC; Bapna A; Ge R; Lim YT; Chuah SC; Sim EK; Wong P
    J Biomed Sci; 2006 Jul; 13(4):579-91. PubMed ID: 16547766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
    Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
    Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium.
    Nurro J; Halonen PJ; Kuivanen A; Tarkia M; Saraste A; Honkonen K; Lähteenvuo J; Rissanen TT; Knuuti J; Ylä-Herttuala S
    Heart; 2016 Nov; 102(21):1716-1720. PubMed ID: 27173504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
    J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
    Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
    Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
    Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
    Rissanen TT; Rutanen J; Ylä-Herttuala S
    Adv Genet; 2004; 52():117-64. PubMed ID: 15522734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits.
    Tanaka E; Hattan N; Ando K; Ueno H; Sugio Y; Mohammed MU; Voltchikhina SA; Mori H
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):720-8. PubMed ID: 11003755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.
    Bougioukas I; Didilis V; Ypsilantis P; Giatromanolaki A; Sivridis E; Lialiaris T; Mikroulis D; Simopoulos C; Bougioukas G
    Cardiovasc Pathol; 2007; 16(2):63-8. PubMed ID: 17317537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor.
    Zhou YF; Stabile E; Walker J; Shou M; Baffour R; Yu Z; Rott D; Yancopoulos GD; Rudge JS; Epstein SE
    J Am Coll Cardiol; 2004 Aug; 44(4):897-903. PubMed ID: 15312878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
    Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
    J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
    Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
    Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.